X

Trial Profile

A Phase II proof-of-concept study of Ocular Bandage Gel (OBG) eye drop in patients with persistent epithelial defects

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 18 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ocular Bandage Gel-Kiora Pharmaceuticals (Primary)
Indications Corneal injuries
Focus Proof of concept; Therapeutic Use
Sponsors Kiora Pharmaceuticals

Most Recent Events

08 Nov 2021 According to Kiora Pharmaceuticals media release, the company plans to report topline proof of concept, exploratory phase 2 clinical trial data in persistent epithelial defect patients in the third quarter of 2022.
20 Aug 2021 New trial record
12 Aug 2021 According to a EyeGate Pharma media release, the company expects to initiate this study in Q4 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com